-
EGRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Eagle Pharmaceuticals (EGRX)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 15.35 mm | 15.35 mm | 15.35 mm | 15.35 mm | 15.35 mm | 15.35 mm |
Cash burn (monthly) | 2.18 mm | 1.77 mm | (no burn) | (no burn) | 42.00 k | 776.50 k |
Cash used (since last report) | 43.80 mm | 35.49 mm | n/a | n/a | 843.42 k | 15.59 mm |
Cash remaining | -28.44 mm | -20.14 mm | n/a | n/a | 14.51 mm | -239.19 k |
Runway (months of cash) | -13.0 | -11.4 | n/a | n/a | 345.5 | -0.3 |
13F holders | Current |
---|---|
Total holders | 13 |
Opened positions | 0 |
Closed positions | 54 |
Increased positions | 4 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 24.47 mm |
Total shares | 6.50 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Nantahala Capital Management | 3.95 mm | $3.16 mm |
Union Square Park Capital Management | 1.49 mm | $1.19 mm |
Scott Tarriff | 992.62 k | $0.00 |
XTX Topco | 23.59 k | $11.80 mm |
Simplex Trading | 18.16 k | $9.00 k |
BCS Barclays | 14.23 k | $7.00 k |
Stanley-Laman | 12.00 k | $6.00 mm |
Acadian Asset Management | 7.16 k | $3.00 k |
Russell Investments | 3.41 k | $1.71 mm |
Archer Investment | 350.00 | $175.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 24 | Scott Tarriff | Common Stock | Payment of exercise | Dispose F | No | No | 6.27 | 2,119 | 13.29 k | 460,621 |
27 Feb 24 | Scott Tarriff | Common Stock | Payment of exercise | Dispose F | No | No | 6.44 | 3,154 | 20.31 k | 462,740 |
27 Feb 24 | Scott Tarriff | Common Stock | Grant | Acquire A | No | No | 0 | 12,950 | 0.00 | 465,894 |
27 Feb 24 | Brian Joseph Cahill | Common Stock | Payment of exercise | Dispose F | No | No | 6.44 | 1,589 | 10.23 k | 47,958 |
27 Feb 24 | Brian Joseph Cahill | Common Stock | Grant | Acquire A | No | No | 0 | 3,800 | 0.00 | 49,547 |
2 Feb 24 | Brian Joseph Cahill | Common Stock | Payment of exercise | Dispose F | No | No | 5.85 | 934 | 5.46 k | 45,747 |